The road to resistance: EGFR mutation and cetuximab

Nat Med. 2012 Feb 6;18(2):199-200. doi: 10.1038/nm.2646.
No abstract available

Publication types

  • News
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Cetuximab
  • Colorectal Neoplasms / drug therapy*
  • Drug Resistance, Neoplasm / genetics*
  • ErbB Receptors / genetics*
  • Humans

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • ErbB Receptors
  • Cetuximab